Dr. Kris on Integrating Driver Mutation Testing Study Results

Mark G. Kris, MD
Published: Friday, Jul 08, 2011



Lead author Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses adjusting practice to integrate the results from the multicenter study focusing on the identification of driver mutations in tumor specimens in patients with lung adenocarcinoma. This study was conducted as part of the American Recovery and Reinvestment act by the National Cancer Institutes' Lung Cancer Mutation Consortium (LCMC).


Lead author Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses adjusting practice to integrate the results from the multicenter study focusing on the identification of driver mutations in tumor specimens in patients with lung adenocarcinoma. This study was conducted as part of the American Recovery and Reinvestment act by the National Cancer Institutes' Lung Cancer Mutation Consortium (LCMC).

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x